Press Releases

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Encore Capital Group, Inc. (Nasdaq: ECPG) (the “Company”) today announced its intention to offer, subject to market and other conditions, $400.0 million aggregate principal amount of senior secured notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) and outside the United States to non-U.S.... (continue reading...)

Vancouver, British Columbia--(Newsfile Corp. - May 13, 2024) - Perseverance Metals Inc. ("Perseverance" or the "Company") is pleased to announce that it appointed: i) Filip Papich and Edie Thome to its Board of Directors; ii) Anil Jiwani as Chief Financial Officer, and iii) Darwin Green as an Advisor to the Company.

Michael Gray, Chairman of Perseverance, commented, "We are very pleased to welcome Filip Papich and Edie Thome to the Perseverance Board as new Independent... (continue reading...)

Toronto, Ontario--(Newsfile Corp. - May 13, 2024) - Gowest Gold Ltd. (TSXV: GWA) ("Gowest" or the "Corporation") is pleased to provide a further update on the latest assay results from Phase 2 of its previously announced surface diamond drill program at its 100% owned North Timmins Gold Project ("NTGP"). This latest work is part of the $10 Million exploration program phase, which aims to expand the mineable resource at the Bradshaw Gold deposit ("Bradshaw"), as well as... (continue reading...)

– NDA for etripamil in PSVT resubmitted in 1Q 2024– Cash resources as of March 31, 2024 expected to fund operations into 2026– Dialogue with FDA to finalize Phase 3 protocol for etripamil in AFib-RVR is progressing

MONTREAL and CHARLOTTE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the first quarter ended March 31, 2024 and provided a regulatory and corporate update.

... (continue reading...)

• Board Urges Shareholders to Vote “FOR” ALL of Gildan’s Recommended Qualified and Experienced Director Nominees on the BLUE Proxy Card
• Vote Today! For questions or help with voting, call 1-888-518-6813 (toll free in North America), text or call 437-561-5012, email [email protected] or visit www.futureofgildan.com

MONTREAL, May 13, 2024 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL; TSX and NYSE) today announced that it has published an investor... (continue reading...)